Evolution of biliopancreatic diversion in the treatment of morbid obesity and type 2 diabetes mellitus
Abstract
The prevalence of morbid obesity is on the rise. Surgical intervention for the treatment of morbid obesity has been shown to provide high metabolic efficiency, acquiring a special role in the treatment of type 2 diabetes mellitus. Various surgical procedures are used in treating morbid obesity. These include gastric-bypass surgery and biliopancreatic bypass diversion (BPD), each with various advantages of its own. In recent years, BPD (also referred to as the Scopinaro procedure) has evolved and been modified into the single anastomosis duodeno-ileal (SADI) procedure. Like other types of BPD, the SADI procedure effectively reduces excess body weight and promotes normalisation of carbohydrate and lipid metabolism, leading to a reduced frequency of insulin therapy and use of antidiabetic drugs. The potential benefits of the procedure include reduced operative time and a reduced incidence of internal hernias. Studies have also shown that the SADI procedure results in fewer early and late post-operative complications. Given the effectiveness of the procedure, it is necessary to increase the number and duration of observations made to enable further insight into the long-term efficacy and use of the SADI procedure.
About the Authors
Natalya S. BordanResearch Center for Obstetrics, Gynecology and Perinatology; Center of Endosurgery and Lithotripsy
Russian Federation
MD, PhD, research associate
Competing Interests:
No conflict of interests
Yuriy I. Yashkov
Research Center for Obstetrics, Gynecology and Perinatology; Center of Endosurgery and Lithotripsy; Endocrinology Research Centre
Russian Federation
MD, PhD, Professor
Competing Interests:
No conflict of interests
References
1. Звенигородская Л.А. Эндоканнабиноидная система, пищевая аддикция, морбидное ожирение. // Consilium medicum. Гастроэнтерология. – 2014. Т. 16. -№8. – С. 67-72. [Zvenigorodskaya LA. Endokannabinoidnaya sistema, pishchevaya addiktsiya, morbidnoe ozhirenie. Consiliummedicum. Gastroenterologiya. 2014;16(8):67-72. (in Russ)]
2. Buschur ME, Smith D, Share D, et al. The burgeoning epidemic of morbid obesity in patients undergoing percutaneous coronary intervention: insight from the Blue Cross Blue Shield of Michigan Cardiovascular Consortium. J Am Coll Cardiol. 2013;62(8):685-691. doi: 10.1016/j.jacc.2013.06.004
3. Flegal KM, Carroll MD, Kit BK, Ogden CL. Prevalence of obesity and trends in the distribution of body mass index among US adults, 1999-2010. JAMA. 2012;307(5):491-497. doi: 10.1001/jama.2012.39
4. Ogden CL, Carroll MD, Kit BK, Flegal KM. Prevalence of obesity and trends in body mass index among US children and adolescents, 1999-2010. JAMA. 2012;307(5):483-490. doi: 10.1001/jama.2012.40
5. Kelly T, Yang W, Chen CS, et al. Global burden of obesity in 2005 and projections to 2030. Int J Obes (Lond). 2008;32(9):1431-1437. doi: 10.1038/ijo.2008.102
6. Fried M, Yumuk V, Oppert JM, et al. Interdisciplinary European Guidelines on metabolic and bariatric surgery. Obes Facts. 2013;6(5):449-468. doi: 10.1159/000355480
7. Stunkard A. Obesity: risk factors, consequences and control. Med J Aust. 1988;148:S21-28.
8. Stunkard AJ. Current views on obesity. Am J Med. 1996;100(2):230-236. doi: 10.1016/s0002-9343(97)89464-8
9. Asensio C, Cettour-Rose P, Theander-Carrillo C, et al. Changes in glycemia by leptin administration or high- fat feeding in rodent models of obesity/type 2 diabetes suggest a link between resistin expression and control of glucose homeostasis. Endocrinology. 2004;145(5):2206-2213. doi: 10.1210/en.2003-1679
10. Dominiczak MH. Obesity, glucose intolerance and diabetes and their links to cardiovascular disease. Implications for laboratory medicine. Clin Chem Lab Med. 2003;41(9):1266-1278. doi: 10.1515/CCLM.2003.194
11. Will JC, Williamson DF, Ford ES, et al. Intentional Weight Loss and 13-Year Diabetes Incidence in Overweight Adults. American Journal of Public Health. 2002;92(8):1245-1248. doi: 10.2105/ajph.92.8.1245
12. Look ARG, Wing RR, Bolin P, et al. Cardiovascular effects of intensive lifestyle intervention in type 2 diabetes. N Engl J Med. 2013;369(2):145-154. doi: 10.1056/NEJMoa1212914
13. James WP, Caterson ID, Coutinho W, et al. Effect of sibutramine on cardiovascular outcomes in overweight and obese subjects. N Engl J Med. 2010;363(10):905-917. doi: 10.1056/NEJMoa1003114
14. Nissen SE, Nicholls SJ, Wolski K, et al. Effect of rimonabant on progression of atherosclerosis in patients with abdominal obesity and coronary artery disease: the STRADIVARIUS randomized controlled trial. JAMA. 2008;299(13):1547-1560. doi: 10.1001/jama.299.13.1547
15. Gazet JC, Pilkington TR. Surgery of morbid obesity. Bmj. 1987;295(6590):72-73. doi: 10.1136/bmj.295.6590.72
16. Sobel RJ, Gert B. Guidelines for surgery for morbid obesity. Am J ClinNutr. 1987;45(4):797-799.
17. Vallis TM, Ross MA. The Role of Psychological Factors in Bariatric Surgery for Morbid Obesity: Identification of Psychological Predictors of Success. Obesity Surgery. 1993;3(4):346-359. doi: 10.1381/096089293765559025
18. Sjostrom L, Peltonen M, Jacobson P, et al. Bariatric surgery and long-term cardiovascular events. JAMA. 2012;307(1):56-65. doi: 10.1001/jama.2011.1914
19. Adams TD, Gress RE, Smith SC, et al. Long-term mortality after gastric bypass surgery. N Engl J Med. 2007;357(8):753-761. doi: 10.1056/NEJMoa066603
20. Buchwald H. The evolution of metabolic/bariatric surgery. Obes Surg. 2014;24(8):1126-1135. doi: 10.1007/s11695-014-1354-3
21. Angrisani L, Santonicola A, Hasani A, et al. Five-year results of laparoscopic sleeve gastrectomy: effects on gastroesophageal reflux disease symptoms and co-morbidities. SurgObesRelatDis. 2016;12(5):960-968.
22. Angrisani L, Santonicola A, Iovino P, et al. Bariatric surgery worldwide 2013. Obes surg. 2015;25(10):1822-1832.
23. Яшков Ю.И., Никольский А.В, Бекузаров Д.К, и др. Cемилетний опыт применения операции билиопанкреатического отведения в модификации Hess-Marceau в лечении морбидного ожирения и сахарного диабета ٢ типа // Ожирение и метаболизм. – 2012. – Т. ٩. – №2. – C. 43-48. [Yashkov YI, Nikol'skiy AV, Bekuzarov DK, et al. A 7-year experience with the surgery of biliopancreatic diversion in the modification of Hess-Marceau for the treatment of morbid obesity and type 2 diabetes. Obesity and metabolism. 2012;9(2):43-48. (in Russ)] doi: 10.14341/omet2012243-48
24. Fisher BL, Schauer P. Medical and surgical options in the treatment of severe obesity. The American Journal of Surgery. 2002;184(6):S9-S16. doi: 10.1016/s0002-9610(02)01173-x
25. Rutledge R. The mini-gastric bypass: experience with the first 1,274 cases. Obes Surg. 2001;11(3):276-280. doi: 10.1381/096089201321336584
26. Arterburn DE, Courcoulas AP. Bariatric surgery for obesity and metabolic conditions in adults. BMJ. 2014;349:g3961. doi: 10.1136/bmj.g3961
27. Scopinaro N, Gianetta E, Civalleri D, et al. Bilio-pancreatic bypass for obesity: II. Initial experience in man. Br J Surg. 1979;66(9):618-620. doi: 10.1002/bjs.1800660906
28. Дедов И.И. Морбидное ожирение / под редакцией Дедова И.И. – М.: ООО МИА; 2014. [Dedov II. Morbidnoe ozhirenie. Ed by Dedov II. – Moscow: OOO MIA; 2014. (in Russ)]
29. Hess DS, Hess DW. Biliopancreatic diversion with a duodenal switch. Obes Surg. 1998;8(3):267-282. doi: 10.1381/096089298765554476
30. Marceau P, Biron S, St Georges R, et al. Biliopancreatic Diversion with Gastrectomy as Surgical Treatment of Morbid Obesity. ObesSurg. 1991;1(4):381-386. doi: 10.1381/096089291765560764
31. DeMeester TR, Fuchs KH, Ball CS, et al. Experimental and Clinical Results with Proximal End-to-End Duodenojejunostomy for Pathologic Duodenogastric Reflux. AnnSurg. 1987;206(4):414-426. doi: 10.1097/00000658-198710000-00003
32. Sanchez-Pernaute A, Rubio MA, Cabrerizo L, et al. Single-anastomosis duodenoileal bypass with sleeve gastrectomy (SADI-S) for obese diabetic patients. Surg Obes Relat Dis. 2015;11(5):1092-1098. doi: 10.1016/j.soard.2015.01.024
33. Hess DS, Hess DW, Oakley RS. The biliopancreatic diversion with the duodenal switch: results beyond 10 years. Obes Surg. 2005;15(3):408-416. doi: 10.1381/0960892053576695
34. Marceau P, Biron S, Hould F-S, et al. Duodenal Switch: Long-Term Results. ObesSurg. 2008;17(11):1421-1430. doi: 10.1007/s11695-008-9435-9
35. Buchwald H, Estok R, Fahrbach K, et al. Weight and type 2 diabetes after bariatric surgery: systematic review and meta-analysis. Am J Med. 2009;122(3):248-256 e245. doi: 10.1016/j.amjmed.2008.09.041
36. Prachand VN, Ward M, Alverdy JC. Duodenal switch provides superior resolution of metabolic comorbidities independent of weight loss in the super-obese (BMI > or = 50 kg/m2) compared with gastric bypass. J Gastrointest Surg. 2010;14(2):211-220. doi: 10.1007/s11605-009-1101-6
37. Sovik TT, Aasheim ET, Taha O, et al. Weight loss, cardiovascular risk factors, and quality of life after gastric bypass and duodenal switch: a randomized trial. Ann Intern Med. 2011;155(5):281-291. doi: 10.7326/0003-4819-155-5-201109060-00005
38. Buchwald H, Oien DM. Metabolic/bariatric surgery worldwide 2011. Obes Surg. 2013;23(4):427-436. doi: 10.1007/s11695-012-0864-0
39. Scopinaro N, Adami GF, Marinari GM, et al. Biliopancreatic Diversion. World J Surg. 1998;22(9):936-946. doi: 10.1007/s002689900497
40. Sanchez-Pernaute A, Herrera MA, Perez-Aguirre ME, et al. Single anastomosis duodeno-ileal bypass with sleeve gastrectomy (SADI-S). One to three-year follow-up. Obes Surg. 2010;20(12):1720-1726. doi: 10.1007/s11695-010-0247-3
41. Frenken M, Cho EY. Metabolic intestinal bypass surgery for type 2 diabetes in patients with a BMI <35 kg/m2: comparative analysis of 16 patients undergoing either BPD, BPD-DS, or RYGB. Obes Facts. 2011;4 Suppl 1:13-17. doi: 10.1159/000327038
42. Mechanick JI, Youdim A, Jones DB, et al. Clinical practice guidelines for the perioperative nutritional, metabolic, and nonsurgical support of the bariatric surgery patient--2013 update: cosponsored by American Association of Clinical Endocrinologists, the Obesity Society, and American Society for Metabolic & Bariatric Surgery. Endocr Pract. 2013;19(2):337-372. doi: 10.4158/EP12437.GL
43. Bloomberg RD, Fleishman A, Nalle JE, et al. Nutritional deficiencies following bariatric surgery: what have we learned? Obes Surg. 2005;15(2):145-154. doi: 10.1381/0960892053268264
44. Ершова Е.В., Яшков Ю.И. Состояние углеводного и липидного обмена у пациентов с ожирением и сахарным диабетом 2 типа после билиопанкреатического шунтирования // Ожирение и метаболизм. – 2013. – Т. 10. – №3. – C. 28-36. [Ershova EV, Yashkov YI. Status of carbohydrate and lipid metabolism in obese patients with type 2 diabetes mellitus after biliopancreatic diversion surgery. Obesity and metabolism. 2013;10(3):28-36. (in Russ)] doi: 10.14341/2071-8713-3862
45. Topart P, Becouarn G, Ritz P. Comparative early outcomes of three laparoscopic bariatric procedures: sleeve gastrectomy, Roux-en-Y gastric bypass, and biliopancreatic diversion with duodenal switch. Surg Obes Relat Dis. 2012;8(3):250-254. doi: 10.1016/j.soard.2011.05.012
46. Chang SH, Stoll CR, Song J, et al. The effectiveness and risks of bariatric surgery: an updated systematic review and meta-analysis, 2003-2012. JAMA Surg. 2014;149(3):275-287. doi: 10.1001/jamasurg.2013.3654
47. Inabnet WB, 3rd, Winegar DA, Sherif B, Sarr MG. Early outcomes of bariatric surgery in patients with metabolic syndrome: an analysis of the bariatric outcomes longitudinal database. J Am Coll Surg. 2012;214(4):550-556; discussion 556-557. doi: 10.1016/j.jamcollsurg.2011.12.019
48. Marsk R, Freedman J, Tynelius P, et al. Antiobesity surgery in Sweden from 1980 to 2005: a population-based study with a focus on mortality. Ann Surg. 2008;248(5):777-781. doi: 10.1097/SLA.0b013e318189b0cf
49. Reoch J, Mottillo S, Shimony A, et al. Safety of laparoscopic vs open bariatric surgery: a systematic review and meta-analysis. Arch Surg. 2011;146(11):1314-1322. doi: 10.1001/archsurg.2011.270
50. Aasheim ET, Bjorkman S, Sovik TT, et al. Vitamin status after bariatric surgery: a randomized study of gastric bypass and duodenal switch. Am J Clin Nutr. 2009;90(1):15-22. doi: 10.3945/ajcn.2009.27583
51. Michaud A, Marchand GB, Nadeau M, et al. Biliopancreatic Diversion with Duodenal Switch in the Elderly: Long-Term Results of a Matched-Control Study. Obes surg. 2016;26(2):350-360.
52. Gracia JA, Martinez M, Elia M, et al. Obesity surgery results depending on technique performed: long-term outcome. Obes Surg. 2009;19(4):432-438. doi: 10.1007/s11695-008-9762-x
53. Smith MD, Patterson E, Wahed AS, et al. Thirty-day mortality after bariatric surgery: independently adjudicated causes of death in the longitudinal assessment of bariatric surgery. Obes Surg. 2011;21(11):1687-1692. doi: 10.1007/s11695-011-0497-8
54. Birkmeyer JD, Finks JF, O'Reilly A, et al. Surgical skill and complication rates after bariatric surgery. N Engl J Med. 2013;369(15):1434-1442. doi: 10.1056/NEJMsa1300625
55. Biertho L, Lebel S, Marceau S, et al. Laparoscopic sleeve gastrectomy: with or without duodenal switch? A consecutive series of 800 cases. Dig Surg. 2014;31(1):48-54. doi: 10.1159/000354313
56. Rabl C, Peeva S, Prado K, et al. Early and late abdominal bleeding after Roux-en-Y gastric bypass: sources and tailored therapeutic strategies. Obes Surg. 2011;21(4):413-420. doi: 10.1007/s11695-011-0354-9
57. Kumar N, Thompson CC. Endoscopic management of complications after gastrointestinal weight loss surgery. Clin Gastroenterol Hepatol. 2013;11(4):343-353. doi: 10.1016/j.cgh.2012.10.043
58. Coblijn UK, Goucham AB, Lagarde SM, et al. Development of ulcer disease after Roux-en-Y gastric bypass, incidence, risk factors, and patient presentation: a systematic review. Obes Surg. 2014;24(2):299-309. doi: 10.1007/s11695-013-1118-5
59. Pories WJ, Swanson MS, MacDonald KG, et al. Who Would Have Thought It? An Operation Proves to Be the Most Effective Therapy for Adult-Onset Diabetes Mellitus. Ann Surg. 1995;222(3):339-352. doi: 10.1097/00000658-199509000-00011
60. DeMaria EJ, Sugerman HJ, Kellum JM, et al. Results of 281 Consecutive Total Laparoscopic Roux-en-Y Gastric Bypasses to Treat Morbid Obesity. Ann Surg. 2002;235(5):640-647. doi: 10.1097/00000658-200205000-00005
61. Rubino F, Gagner M, Gentileschi P, et al. The Early Effect of the Roux-en-Y Gastric Bypass on Hormones Involved in Body Weight Regulation and Glucose Metabolism. Ann Surg. 2004;240(2):236-242. doi: 10.1097/01.sla.0000133117.12646.48
62. Rubino F, Marescaux J. Effect of duodenal-jejunal exclusion in a non-obese animal model of type 2 diabetes: a new perspective for an old disease. Ann Surg. 2004;239(1):1-11. doi: 10.1097/01.sla.0000102989.54824.fc
63. Kawada T. Bariatric Surgery in Patients With Type 2 Diabetes Mellitus. Ann Surg. 2015. doi: 10.1097/SLA.0000000000001379
64. Cho EY, Kemmet O, Frenken M. Biliopancreatic diversion with duodenal switch in patients with type 2 diabetes mellitus: is the chance of complete remission dependent on therapy and duration of insulin treatment? Obes Facts. 2011;4 Suppl 1:18-23. doi: 10.1159/000327037
65. Buchwald H, Rucker R. The rise and fall of jejunoileal bypass. Surgery of the small intestine. Appleton Century Crofts, Norwalk, CT. 1987:529-541.
66. Schauer PR, Ikramuddin S, Gourash W, et al. Outcomes After Laparoscopic Roux-en-Y Gastric Bypass for Morbid Obesity. Ann Surg. 2000;232(4):515-529. doi: 10.1097/00000658-200010000-00007.
67. Colquitt JL, Pickett K, Loveman E, Frampton GK. Surgery for weight loss in adults. Cochrane Database Syst Rev. 2014(8):CD003641. doi: 10.1002/14651858.CD003641.pub4
68. Renard E. Bariatric surgery in patients with late-stage type 2 diabetes: expected beneficial effects on risk ratio and outcomes. Diabetes Metabol. 2009;35(6):564-568. doi: 10.1016/s1262-3636(09)73467-6
Supplementary files
|
|
1. Рис. 1. Схема операций с комбинированным типом действия (адаптировано [26]). | |
| Subject | ||
| Type | Исследовательские инструменты | |
View
(409KB)
|
Indexing metadata ▾ | |
|
|
2. Рис. 2. Двенадцатиперстно-подвздошное шунтирование с одним анастомозом и рукавной гастрэктомией (SADI) (адаптировано [40]). | |
| Subject | ||
| Type | Исследовательские инструменты | |
View
(340KB)
|
Indexing metadata ▾ | |
Review
For citations:
Bordan N.S., Yashkov Yu.I. Evolution of biliopancreatic diversion in the treatment of morbid obesity and type 2 diabetes mellitus. Diabetes mellitus. 2017;20(3):201-209. (In Russ.)
Views:
1874
Email this article 
